ATE311197T1 - Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit - Google Patents
Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeitInfo
- Publication number
- ATE311197T1 ATE311197T1 AT99943391T AT99943391T ATE311197T1 AT E311197 T1 ATE311197 T1 AT E311197T1 AT 99943391 T AT99943391 T AT 99943391T AT 99943391 T AT99943391 T AT 99943391T AT E311197 T1 ATE311197 T1 AT E311197T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- therapeutic agent
- preventive
- preventives
- remedies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seal Device For Vehicle (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Lubricants (AREA)
- Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26300498 | 1998-09-17 | ||
PCT/JP1999/005080 WO2000016795A1 (fr) | 1998-09-17 | 1999-09-17 | Agents pour la prevention et/ou le traitement de l'obesite |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311197T1 true ATE311197T1 (de) | 2005-12-15 |
Family
ID=17383564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99943391T ATE311197T1 (de) | 1998-09-17 | 1999-09-17 | Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit |
Country Status (7)
Country | Link |
---|---|
US (1) | US6815417B1 (de) |
EP (1) | EP1121936B1 (de) |
AT (1) | ATE311197T1 (de) |
AU (1) | AU759409B2 (de) |
CA (1) | CA2342834A1 (de) |
DE (1) | DE69928685T2 (de) |
WO (1) | WO2000016795A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6902890B1 (en) | 1999-11-04 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing monitoring, staging, imaging and treating cancer |
EP2255825A4 (de) * | 2008-01-25 | 2011-09-14 | Regeron Inc | Zusammensetzung zur prävention oder behandlung von gehirnerkrankungen |
US8569240B2 (en) | 2008-01-25 | 2013-10-29 | Regeron, Inc. | Methods of preventing or treating brain diseases |
JP5946191B2 (ja) * | 2011-07-09 | 2016-07-05 | 国立大学法人東北大学 | 線維症予防又は治療用医薬組成物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988003949A1 (en) * | 1986-11-21 | 1988-06-02 | Howard Florey Institute Of Experimental Physiology | The cs protein of the corpuscles of stannius |
US5837498A (en) * | 1994-03-08 | 1998-11-17 | Human Genome Scienes, Inc. | Corpuscles of stannius protein, stanniocalcin |
-
1999
- 1999-09-17 US US09/787,397 patent/US6815417B1/en not_active Expired - Fee Related
- 1999-09-17 AU AU56532/99A patent/AU759409B2/en not_active Ceased
- 1999-09-17 AT AT99943391T patent/ATE311197T1/de not_active IP Right Cessation
- 1999-09-17 WO PCT/JP1999/005080 patent/WO2000016795A1/ja active IP Right Grant
- 1999-09-17 EP EP99943391A patent/EP1121936B1/de not_active Expired - Lifetime
- 1999-09-17 DE DE69928685T patent/DE69928685T2/de not_active Expired - Fee Related
- 1999-09-17 CA CA002342834A patent/CA2342834A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU759409B2 (en) | 2003-04-17 |
EP1121936A4 (de) | 2004-11-17 |
WO2000016795A1 (fr) | 2000-03-30 |
EP1121936B1 (de) | 2005-11-30 |
DE69928685T2 (de) | 2006-08-24 |
US6815417B1 (en) | 2004-11-09 |
EP1121936A1 (de) | 2001-08-08 |
AU5653299A (en) | 2000-04-10 |
CA2342834A1 (en) | 2000-03-30 |
DE69928685D1 (de) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE297204T1 (de) | Heilmittel für neurodegenerative krankheiten | |
DE69732170D1 (de) | Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan | |
ATE177949T1 (de) | Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie | |
ATE316786T1 (de) | Behandlung von mukositis | |
BG106450A (en) | Use of retigabin for treating neuropathic pain | |
DE69422450D1 (de) | Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose | |
ATE271385T1 (de) | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia | |
ATE452640T1 (de) | Mittel für erkrankungen assoziert mit knochensubstanzverlust | |
BR9913831A (pt) | Processo para tratamento de arteriosclerose empregando um inibidor de ap2 e combinação | |
FI951856A0 (fi) | Farmaseuttinen koostumus osteoporoosin hoitamiseksi | |
ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
ATE311197T1 (de) | Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit | |
DE60142308D1 (de) | Vorbeugungs- oder heilmittel gegen endometriose | |
BR9808299A (pt) | O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca | |
ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto | |
ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür | |
BR9915292A (pt) | Associação, utilização de riluzol e composição farmacêutica. | |
DE69932434D1 (de) | Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten | |
ATE314854T1 (de) | Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs | |
DE69833317D1 (de) | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |